Avid Bioservices (CDMO) Tops Q4 EPS by 12c

Avid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.03), $0.12 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.94 million versus the consensus estimate of $6.14 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Paychex beats fourth quarter EPS estimates, stock slides
• Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq